LAURA GOLDSMITH: Open Payments
NPI 1629624077 · SANTA MONICA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$149 in 6 payments from 5 companies in 2025. Trend: 2023 $16 · 2024 $19 · 2025 $149
Food & beverage: $149
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 2 | $49 |
| Gilead Sciences, Inc. | 1 | $35 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| Amgen Inc. | 1 | $22 |
| Alnylam Pharmaceuticals Inc. | 1 | $22 |
Products named: MOUNJARO, GEMTESA, EVENITY, AMVUTTRA.
Industry payments across CA — which companies pay providers there.
